Title |
Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites
|
---|---|
Published in |
Memórias do Instituto Oswaldo Cruz, November 2015
|
DOI | 10.1590/0074-02760150163 |
Pubmed ID | |
Authors |
Nicolli Bellotti de Souza, Anna Caroline Campos Aguiar, Alane Cabral de Oliveira, Siden Top, Pascal Pigeon, Gérard Jaouen, Marilia Oliveira Fonseca Goulart, Antoniana Ursine Krettli |
Abstract |
This work reports the in vitro activity against Plasmodium falciparumblood forms (W2 clone, chloroquine-resistant) of tamoxifen-based compounds and their ferrocenyl (ferrocifens) and ruthenocenyl (ruthenocifens) derivatives, as well as their cytotoxicity against HepG2 human hepatoma cells. Surprisingly with these series, results indicate that the biological activity of ruthenocifens is better than that of ferrocifens and other tamoxifen-like compounds. The synthesis of a new metal-based compound is also described. It was shown, for the first time, that ruthenocifens are good antiplasmodial prototypes. Further studies will be conducted aiming at a better understanding of their mechanism of action and at obtaining new compounds with better therapeutic profile. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 44 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 23% |
Student > Bachelor | 7 | 16% |
Student > Ph. D. Student | 5 | 11% |
Professor | 3 | 7% |
Student > Doctoral Student | 3 | 7% |
Other | 12 | 27% |
Unknown | 4 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 13 | 30% |
Biochemistry, Genetics and Molecular Biology | 4 | 9% |
Agricultural and Biological Sciences | 4 | 9% |
Engineering | 3 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Other | 7 | 16% |
Unknown | 11 | 25% |